Why Did Drug Spending Increase during the 1990s? A Decomposition Based on Swedish Data

PharmacoEconomics

Volumn 22, Issue 1, 2004, Pages 29-42

  Gerdtham, Ulf G ^a,c   Lundin, Douglas ^b  

^a LUND UNIVERSITY   (Sweden)

^b Swedish Pharmaceutical Benefits Board (LFN)   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; DIGESTIVE TRACT AGENT; HORMONE; IMMUNOSUPPRESSIVE AGENT; RESPIRATORY TRACT AGENT; SEX HORMONE;

ARTICLE; DRUG CLASSIFICATION; DRUG COST; DRUG MARKETING; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; METABOLISM; OUTPATIENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REIMBURSEMENT; SWEDEN;

DRUG COSTS; DRUGS, NON-PRESCRIPTION; ECONOMICS, PHARMACEUTICAL; HUMANS; MODELS, ECONOMIC; PRESCRIPTION FEES; PRESCRIPTIONS, DRUG; SWEDEN;

EID: 0442276037     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200422010-00003     Document Type: Article

References (21)

1. Gerdtham UG, Johannesson M, Jönsson B. Drug spending and new drug introductions: the Swedish experience. Pharmacoeconomics 1993; 13 (2): 215-25
2. Gerdtham UG, Johannesson M, Gunnarsson B, et al. The effect on drug spending of changes in treatment patterns. Pharmacoeconomics 1998; 13 (1 Pt 2): 127-34
3. Dubois RW, Chawla AJ, Neslusan CA, et al. Explaining drug spending trends: does perception match reality. Health Aff 2000; 19: 231-9
4. Crown W, Ling D, Berndt E. Measuring the costs and benefits of pharmaceutical expenditures. Exp Rev Pharmacoeconomics Outcomes Res 2002; 2: 89-97
5. Hjortsberg C, Ghatnekar O. Health care in transition. Copenhagen: European Observervatory on Health Care Systems, 2001
6. Gerdtham UG, Johannesson M, Gunnarsson B, et al. Price indices of drugs and the switching to new drugs. Pharmacoeconomics 1997; 13: 71-80
7. Svensk läkemedelsstatistik. Stockholm: Apoteket AB, 2000
8. Ont i magen - metoder för diagnos och behandling av dyspepsi [in Swedish]. Stockholm: SBU, 2000
9. Schweitzer S. Pharmaceutical economics and policy. New York: Oxford University Press, 1997
10. Ekelund M, Persson M. Pharmaceutical pricing in a regulated market. In: I Ekelund M. Competition and innovation in the Swedish pharmaceutical market. Doktorsavhandling: Handelshögskolan i Stockholm, 2001
11. Coscelli A, Shum M. Empirically characterising informational barriers to entry in the anti-ulcer drug market. Toronto: Department of Economics, University of Toronto, 1998
12. Lichtenberg F. Pharmaceutical innovation, mortality reduction, and economic growth. Working paper 6569. Cambridge: National Bureau of Economic Research, 1998
13. Lichtenberg F. Are the benefits of newer drugs worth their cost: evidence from the 1996 MEPS. Health Aff 2001; 5: 241-51
14. Lichtenberg F, Pharmaceutical innovation as a process of creative destruction. New York: Columbia University and National Bureau of Economic Research, 1998 Feb
15. Jönsson B, Gerdtham UG. Cost-sharing for pharmaceuticals: The Swedish reimbursement system. In: Mattison N, editor. Sharing the costs of health: a multi-country perspective. Basel: The Pharmaceutical Partners for Better Healthcare, 1995: 3-71
16. Geweke J, Weisbrod BA. Expenditure effects of technological change: the case of a drug. Eval Rev 1984; 8: 74-92
17. Jönsson B, Carlsson P. The effects of cimetidine on the cost of ulcer disease in Sweden. Soc Sci Med 1991; 33: 275-82
18. Ädelroth E, Thompson S. Högdosinhalationssteroider vid astma: analys av kostnader och vårdutnyttjande. Lakartidningen 1984; 81: 4285-4288
19. Ädelroth E, Thompson S. Advantages of high-dose inhaled budesonide. Lancet 1988, II; 476
20. Gerdtham UG, Hertzman P, Boman G, et al. Impact of inhaled corticosteroids on asthma hospitalization in Sweden. Appl Econ 1996; 15: 1591-9
21. Gerdtham UG, Hertzman P, Boman G, et al. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden, 1978-1991. Med Care 1996; 34: 1188-98